Heart rhythm (QT interval)

Every manufacturer places this the same way.

scroll for all 10 products →

Which section of each manufacturer's label carries this concept
Section	Brown & Burk UK Ltd10mg Tablets	Strides Pharma UK Ltd10mg Tablets	Flamingo Pharma (UK) Ltd10mg Tablets	Wockhardt UK Ltd10mg/5ml Oral Solution	Flamingo Pharma (UK) Ltd25mg Tablets	Wockhardt UK Ltd25mg/5ml Oral Solution	Wockhardt UK Ltd50mg/5ml Oral Solution	Rosemont Pharmaceuticals Limited50mg/5ml Oral Solution	Amarox Limited10mg Tablets	SyriMed10mg/5ml Oral Solution
ContraindicatedThe label says it must not be used.
WarningThe label says it can be used, with care.	Warning	Warning	Warning	Warning	Warning	Warning	Warning	Warning	Warning	Warning
InteractionThe label says another medicine affects it.
PregnancyThe label gives advice for pregnancy or breastfeeding.
ExcipientThe label lists it as an ingredient, not a restriction.

Warning
- Brown & Burk UK Ltd
  10mg Tablets · revised 26/03/2025
  0–166 of 6268 characters
  Source SmPC ↗
- Strides Pharma UK Ltd
  10mg Tablets · revised 01/09/2025
  0–166 of 6143 characters
  Source SmPC ↗
- Flamingo Pharma (UK) Ltd
  10mg Tablets · revised 30/06/2025
  0–166 of 6144 characters
  Source SmPC ↗
- Wockhardt UK Ltd
  10mg/5ml Oral Solution · revised 30/04/2025
  0–166 of 5632 characters
  Source SmPC ↗
- Flamingo Pharma (UK) Ltd
  25mg Tablets · revised 04/11/2025
  0–166 of 6142 characters
  Source SmPC ↗
- Wockhardt UK Ltd
  25mg/5ml Oral Solution · revised 30/04/2025
  687–853 of 5631 characters
  Source SmPC ↗
- Wockhardt UK Ltd
  50mg/5ml Oral Solution · revised 30/04/2025
  687–853 of 5631 characters
  Source SmPC ↗
- Rosemont Pharmaceuticals Limited
  50mg/5ml Oral Solution · revised 01/04/2025
  0–166 of 6250 characters
  Source SmPC ↗
- Amarox Limited
  10mg Tablets · revised 03/06/2025
  717–883 of 6360 characters
  Source SmPC ↗
- SyriMed
  10mg/5ml Oral Solution · revised 09/12/2025
  0–166 of 6202 characters
  Source SmPC ↗
Cardiac arrhythmias and severe hypotension are likely to occur with high dosage. They may also occur in patients with pre-existing heart disease taking normal dosage. QT interval prolongation Cases of QT interval prolongation and arrhythmia have been reported during the post-marketing period. Caution is advised in patients with significant bradycardia, in pati
Identical in all 10 labels. Surrounding text shown from Brown & Burk UK Ltd.